Cargando…

Erratum: The Regulation of Insulin-Stimulated Cardiac Glucose Transport via Protein Acetylation

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052770/ https://www.ncbi.nlm.nih.gov/pubmed/30038909 http://dx.doi.org/10.3389/fcvm.2018.00103

Ejemplares similares

The Regulation of Insulin-Stimulated Cardiac Glucose Transport via Protein Acetylation
por: Renguet, Edith, et al.
Publicado: (2018)

Post-translational Acetylation Control of Cardiac Energy Metabolism
por: Ketema, Ezra B., et al.
Publicado: (2021)

Roles of histone acetylation sites in cardiac hypertrophy and heart failure
por: Funamoto, Masafumi, et al.
Publicado: (2023)

Metabolic Syndrome Is Associated With Impaired Insulin-Stimulated Myocardial Glucose Metabolic Rate in Individuals With Type 2 Diabetes: A Cardiac Dynamic (18)F-FDG-PET Study
por: Succurro, Elena, et al.
Publicado: (2022)

Sex-dependent transcription of cardiac electrophysiology and links to acetylation modifiers based on the GTEx database
por: Pressler, Michael P., et al.
Publicado: (2022)

Antiretroviral Drugs Regulate Epigenetic Modification of Cardiac Cells Through Modulation of H3K9 and H3K27 Acetylation
por: Kashyap, Shiridhar, et al.
Publicado: (2021)

Updated Understanding of the Crosstalk Between Glucose/Insulin and Cholesterol Metabolism
por: Xiao, Xuan, et al.
Publicado: (2022)

Cardiovascular outcomes in patients treated with sodium-glucose transport protein 2 inhibitors, a network meta-analysis of randomized trials
por: Tornyos, Dániel, et al.
Publicado: (2022)

Mechanisms and Perspectives of Sodium-Glucose Co-transporter 2 Inhibitors in Heart Failure
por: Zeng, Qingchun, et al.
Publicado: (2021)

Clinical benefit of sodium-glucose transport protein-2 inhibitors in patients with heart failure: An updated meta-analysis and trial sequential analysis
por: Chen, Xiehui, et al.
Publicado: (2022)

Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary
por: Mascolo, Annamaria, et al.
Publicado: (2022)

Vascular Endothelial Regulation of Obesity-Associated Insulin Resistance
por: Li, Manna, et al.
Publicado: (2017)

Metabolic Regulation of Cardiac Regeneration
por: Duan, Xuewen, et al.
Publicado: (2022)

The Triglyceride-Glucose Index, an Insulin Resistance Marker, Was Non-linear Associated With All-Cause and Cardiovascular Mortality in the General Population
por: Liu, Xiao-cong, et al.
Publicado: (2021)

Effect of Sodium-Glucose Co-transporter Protein 2 Inhibitors on Arrhythmia in Heart Failure Patients With or Without Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials
por: Yin, Ziwei, et al.
Publicado: (2022)

Cardiac-Specific Deletion of Pyruvate Dehydrogenase Impairs Glucose Oxidation Rates and Induces Diastolic Dysfunction
por: Gopal, Keshav, et al.
Publicado: (2018)

Lysosomal-Associated Protein Transmembrane 5 Functions as a Novel Negative Regulator of Pathological Cardiac Hypertrophy
por: Gao, Lu, et al.
Publicado: (2021)

Visit-to-Visit Fasting Glucose Variability in Young Adulthood and Cardiac Structure and Function at Midlife: The CARDIA Study
por: Xiong, Zhenyu, et al.
Publicado: (2021)

S-Propargyl-Cysteine Attenuates Diabetic Cardiomyopathy in db/db Mice Through Activation of Cardiac Insulin Receptor Signaling
por: Li, Ye, et al.
Publicado: (2021)

Potential favorable action of sodium-glucose cotransporter-2 inhibitors on sudden cardiac death: a brief overview
por: Sato, Tatsuya, et al.
Publicado: (2023)

Decrease of Cardiac Parkin Protein in Obese Mice
por: Thomas, Amandine, et al.
Publicado: (2020)

Vagus Nerve Stimulation in Early Stage of Acute Myocardial Infarction Prevent Ventricular Arrhythmias and Cardiac Remodeling
por: Zhao, Shuang, et al.
Publicado: (2021)

Glucose Fluctuations Aggravate Myocardial Fibrosis via the Nuclear Factor-κB-Mediated Nucleotide-Binding Oligomerization Domain-Like Receptor Protein 3 Inflammasome Activation
por: Zhang, Zhen-Ye, et al.
Publicado: (2022)

Investigating the roles of hyperglycaemia, hyperinsulinaemia and elevated free fatty acids in cardiac function in patients with type 2 diabetes via treatment with insulin compared with empagliflozin: protocol for the HyperCarD2 randomised, crossover trial
por: Thirumathyam, Roopameera, et al.
Publicado: (2022)

LncRNA TUG1 Regulates Proliferation of Cardiac Fibroblast via the miR-29b-3p/TGF-β1 Axis
por: Guo, Yini, et al.
Publicado: (2021)

Sodium-Glucose Co-transporter-2 Inhibitor of Dapagliflozin Attenuates Myocardial Ischemia/Reperfusion Injury by Limiting NLRP3 Inflammasome Activation and Modulating Autophagy
por: Yu, Yong-Wei, et al.
Publicado: (2022)

Selective protein kinase C inhibition switches time-dependent glucose cardiotoxicity to cardioprotection
por: Brennan, Sean, et al.
Publicado: (2022)

Stimulating myocardial pyruvate dehydrogenase activity fails to alleviate cardiac abnormalities in a mouse model of human Barth syndrome
por: Greenwell, Amanda A., et al.
Publicado: (2022)

Sodium-glucose co-transporter-2 inhibitors reduce the risk of new-onset stroke in patients with type 2 diabetes: A population-based cohort study
por: Lin, Tsung-Kun, et al.
Publicado: (2022)

The Roles of the LIM Domain Proteins in Drosophila Cardiac and Hematopoietic Morphogenesis
por: She, Meihua, et al.
Publicado: (2021)

Implications of S-glutathionylation of sarcomere proteins in cardiac disorders, therapies, and diagnosis
por: Rosas, Paola C., et al.
Publicado: (2023)

Perivascular Adipose-Derived Exosomes Reduce Foam Cell Formation by Regulating Expression of Cholesterol Transporters
por: Liu, Yan, et al.
Publicado: (2021)

Dioscin Alleviates Cardiac Dysfunction in Acute Myocardial Infarction via Rescuing Mitochondrial Malfunction
por: Shen, Tianyu, et al.
Publicado: (2022)

Cardiac ISL1-Interacting Protein, a Cardioprotective Factor, Inhibits the Transition From Cardiac Hypertrophy to Heart Failure
por: Yan, Youchen, et al.
Publicado: (2022)

Triglyceride-Glucose Index and Homeostasis Model Assessment-Insulin Resistance in Young Adulthood and Risk of Incident Congestive Heart Failure in Midlife: The Coronary Artery Risk Development in Young Adults Study
por: Zeng, Xianghui, et al.
Publicado: (2022)

Direct Cardiac Actions of Sodium-Glucose Cotransporter 2 Inhibition Improve Mitochondrial Function and Attenuate Oxidative Stress in Pressure Overload-Induced Heart Failure
por: Li, Xuan, et al.
Publicado: (2022)

Case report: Sodium-glucose cotransporter 2 inhibitors induce left ventricular reverse remodeling in anthracycline-related cardiac dysfunction—a case series
por: Giangiacomi, Francesco, et al.
Publicado: (2023)

Secreted Frizzled-Related Protein 5 Protects Against Cardiac Rupture and Improves Cardiac Function Through Inhibiting Mitochondrial Dysfunction
por: Huang, Xin, et al.
Publicado: (2021)

A Dual Role for Death Receptor 5 in Regulating Cardiac Fibroblast Function
por: Tanner, Miles A., et al.
Publicado: (2021)

TANK Promotes Pressure Overload Induced Cardiac Hypertrophy via Activating AKT Signaling Pathway
por: Pang, Yanan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2qd25gpn8vv4hsaue2b4trg3r4